Raphael Pharmaceutical annual free cash flow
2022
Raphael Pharmaceutical Free Cash Flow (FCF) History (RAPH)
Raphael Pharmaceutical reported −$761,000 in free cash flow for fiscal 2022.
View full Raphael Pharmaceutical company overviewRaphael Pharmaceutical free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$761,000 | — | — | — |
Raphael Pharmaceutical quarterly free cash flow
Q1.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q1 2024 | 2024-03-31 | −$173,000 | — | — | — |
Raphael Pharmaceutical free cash flow growth trends
Raphael Pharmaceutical's latest reported quarter, Q1 2024, generated −$173,000 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Raphael Pharmaceutical source filings ↗